Glioblastoma: State of the Art and Future Perspectives
Glioblastoma is an aggressive incurable primary tumor of the central nervous system. Median overall survival is in the range of 1.5 years even in selected clinical trials populations. Many features contribute to this therapeutic challenge including high intratumoral and intertumoral heterogeneity, r...
Saved in:
HerausgeberIn: | |
---|---|
Sonstige: | |
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (784 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545833404498 |
---|---|
ctrlnum |
(CKB)5400000000044634 (oapen)https://directory.doabooks.org/handle/20.500.12854/68811 (EXLCZ)995400000000044634 |
collection |
bib_alma |
record_format |
marc |
spelling |
Tabatabai, Ghazaleh edt Glioblastoma: State of the Art and Future Perspectives Glioblastoma Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (784 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Glioblastoma is an aggressive incurable primary tumor of the central nervous system. Median overall survival is in the range of 1.5 years even in selected clinical trials populations. Many features contribute to this therapeutic challenge including high intratumoral and intertumoral heterogeneity, resistance to therapy, migration and invasion, immunosuppression. With the access of novel highthroughput technologies, significant progress has been made to understand molecular and immunological signatures underlying the pathology of glioblastoma. Clinical trial designs have shifted from investigating broad “one-for-all” treatment approaches to precision oncology designs. The collection of contributions in this book aim at providing researchers and clinicians an update on different aspects of glioblastoma, i.e. progress in basic, preclinical and clinical research. English Research & information: general bicssc Biology, life sciences bicssc 3-03928-260-3 3-03928-261-1 Wakimoto, Hiroaki edt Tabatabai, Ghazaleh oth Wakimoto, Hiroaki oth |
language |
English |
format |
eBook |
author2 |
Wakimoto, Hiroaki Tabatabai, Ghazaleh Wakimoto, Hiroaki |
author_facet |
Wakimoto, Hiroaki Tabatabai, Ghazaleh Wakimoto, Hiroaki |
author2_variant |
g t gt h w hw |
author2_role |
HerausgeberIn Sonstige Sonstige |
title |
Glioblastoma: State of the Art and Future Perspectives |
spellingShingle |
Glioblastoma: State of the Art and Future Perspectives |
title_full |
Glioblastoma: State of the Art and Future Perspectives |
title_fullStr |
Glioblastoma: State of the Art and Future Perspectives |
title_full_unstemmed |
Glioblastoma: State of the Art and Future Perspectives |
title_auth |
Glioblastoma: State of the Art and Future Perspectives |
title_alt |
Glioblastoma |
title_new |
Glioblastoma: State of the Art and Future Perspectives |
title_sort |
glioblastoma: state of the art and future perspectives |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (784 p.) |
isbn |
3-03928-260-3 3-03928-261-1 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT tabatabaighazaleh glioblastomastateoftheartandfutureperspectives AT wakimotohiroaki glioblastomastateoftheartandfutureperspectives AT tabatabaighazaleh glioblastoma AT wakimotohiroaki glioblastoma |
status_str |
n |
ids_txt_mv |
(CKB)5400000000044634 (oapen)https://directory.doabooks.org/handle/20.500.12854/68811 (EXLCZ)995400000000044634 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Glioblastoma: State of the Art and Future Perspectives |
author2_original_writing_str_mv |
noLinkedField noLinkedField noLinkedField |
_version_ |
1787548708888379393 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01972nam-a2200337z--4500</leader><controlfield tag="001">993545833404498</controlfield><controlfield tag="005">20231214133238.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000044634</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68811</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000044634</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tabatabai, Ghazaleh</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Glioblastoma: State of the Art and Future Perspectives</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Glioblastoma</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (784 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Glioblastoma is an aggressive incurable primary tumor of the central nervous system. Median overall survival is in the range of 1.5 years even in selected clinical trials populations. Many features contribute to this therapeutic challenge including high intratumoral and intertumoral heterogeneity, resistance to therapy, migration and invasion, immunosuppression. With the access of novel highthroughput technologies, significant progress has been made to understand molecular and immunological signatures underlying the pathology of glioblastoma. Clinical trial designs have shifted from investigating broad “one-for-all” treatment approaches to precision oncology designs. The collection of contributions in this book aim at providing researchers and clinicians an update on different aspects of glioblastoma, i.e. progress in basic, preclinical and clinical research.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research & information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biology, life sciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-260-3</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-261-1</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wakimoto, Hiroaki</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tabatabai, Ghazaleh</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Wakimoto, Hiroaki</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:47:37 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338102540004498&Force_direct=true</subfield><subfield code="Z">5338102540004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338102540004498</subfield></datafield></record></collection> |